Enzyme Replacement Therapy in Mucopolysaccharidosis I: Altered Distribution and Targeting of α-l-Iduronidase in Immunized Rats
Authors:
- John J. HopwoodJHJohn J. Hopwood
- Doug A. BrooksDoug A. Brooks
- 1 April 2000
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 69 (4) , 277-285
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Immune Response to Enzyme Replacement Therapy in Lysosomal Storage Disorder Patients and Animal ModelsMolecular Genetics and Metabolism, 1999
- Immune Response to Enzyme Replacement Therapy: 4-Sulfatase Epitope Reactivity of Plasma Antibodies from MPS VI CatsMolecular Genetics and Metabolism, 1999
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.Journal of Clinical Investigation, 1998
- Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.Journal of Clinical Investigation, 1997
- Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis IBiochemical and Molecular Medicine, 1996
- Current Issues in Enzyme Therapy for Gaucher DiseaseDrugs, 1996
- Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.Journal of Clinical Investigation, 1996
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.Journal of Clinical Investigation, 1994
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981
- The SphingolipidosesNew England Journal of Medicine, 1966